Aug 2 2019 This Week in Cardiology Aug 2 2019 This Week in Cardiology
Digoxin, acupuncture and angina, heart failure with preserved ejection fraction, bariatric surgery, and cardiac device complications are the topics John Mandrola covers in this week's podcast.theheart.org on Medscape
CONCLUSIONS This work provides a useful method to increase coronary perfusion and may be beneficial for improving myocardial function in patients with end-stage heart failure, especially those with ischemic cardiomyopathy (ICM). PMID: 32940255 [PubMed - in process]
Condition: Heart Failure Intervention: Biological: Biomarker guided therapy Sponsors: University Hospital, Montpellier; EURO BIO Scientific Not yet recruiting
Authors: Michas G, Magriplis E, Panagiotakos D, Chourdakis M, Micha R, Filippatos G, Zampelas A, Dimakopoulos I, Karageorgou D, Mitsopoulou AV, Bakogianni I, Ntouroupi T, Tsaniklidou SM, Argyri K, Fappa E, Theodoraki EM, Trichia E, Sialvera TE, Varytimiadi A, Spyreli E, Koutelidakis A, Karlis G, Zacharia S, Papageorgiou A, Advisory Committee, Chrousos GP, Dedoussis G, Dimitriadis G, Manios Y, Roma E PMID: 32941987 [PubMed - as supplied by publisher]
PMID: 32929710 [PubMed - in process]
CONCLUSIONS: AD is responsible for an increasing proportion of hospitalizations in Spain and raising medical costs, which highlights the importance of early detection and optimized care. PMID: 32928002 [PubMed - as supplied by publisher]
Conclusions: As postoperative mortality in case of COVID pneumonia is not negligible, meticulous rules (precise triage, safe hospital path, high level of protection for health-care teams, prompt diagnosis of suspicious symptoms) should be strictly followed in patients undergoing CS during COVID pandemic. The role of therapies alternative to CS should be further assessed.
Conclusions: This large matched-cohort study identified the minimum weight loss thresholds for reduction in risk of MACE and all-cause mortality in patients with obesity and diabetes. Furthermore, in our analysis, the effect of surgery was still present after accounting for weight loss, which may suggest the presence of weight-independent beneficial effects of metabolic surgery on MACE and survival.
We request that the following corrections be made in our article.
Atrial fibrillation and peripheral arterial disease are two conditions associated with high risk of cardiovascular and cerebrovascular complications and mortality.1 –5 There is evidence that coexistence of both these clinical conditions can result to an additive risk of adverse events.6 Indeed, atherosclerotic vascular disease has been linked with stroke, thromboembolism and death in subjects with atrial fibrillation and has been therefore included as one of the components of risk scores, such as the CHA2DS2-VASc score (Congestive Heart failure, Hypertension Age> 75 years, DM, Stroke, Vascular disease) in order to...
New sports cardiology guidelines green-light participation in vigorous competitive sports by selected patients with stable coronary artery disease, heart failure, or mild arrhythmiasMedscape Medical News